Enhanced renoprotective effects of ultra high doses of irbesartan in patients with type 2 diabetes and microalbuminuria

K Rossing, KJ Schjoedt, BR Jensen, F Boomsma, HH Parving

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)A5-A6
JournalDiabetologia
Volume48
Publication statusPublished - 2005

Research programs

  • EMC COEUR-01-43-01

Cite this